Mayfair Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
N
Mayfair Advisory Group's AMGN Position: Q2 2026 in Review
Mayfair Advisory Group reduced its Amgen (AMGN) stake by 0.8% in Q2 2026, selling an estimated $2.74K and leaving 987 shares worth $371K. The position accounts for 0.11% of the portfolio, ranked #135.
Mayfair Advisory Group first reported a position in AMGN in Q3 2020 and has held it in 19 quarters since. 2,406 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mayfair Advisory Group held 987 shares of Amgen worth $371K as of Q2 2026.
- Mayfair Advisory Group sold 8 Amgen shares in Q2 2026, an estimated $2.74K.
- Amgen made up 0.11% of Mayfair Advisory Group's portfolio in Q2 2026, its #135 holding.
- Mayfair Advisory Group first reported a position in Amgen in Q3 2020 and has held it in 19 quarters since.
- 2,406 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mayfair Advisory Group's 13F filing for Q2 2026, filed 11 Aug 2026.